- International Pharmaceutical Expo (INTERPHEX), the premier event dedicated to pharmaceutical and biotechnology innovation, technology and knowledge from development through commercialization, today released the upcoming schedule of virtual content taking place over the next month. The Road to New York starts here, pre-register for 2021 and receive important show notifications. The next in-person edition of INTERPHEX takes place October 19-21, 2021 at the Javits Center in New York, New York.
“INTERPHEX has been developing digital channels beyond the show floor to provide virtual opportunities for the industry to come together throughout the year,” said Kate Scott, Event Vice President, INTERPHEX. “The team has been transitioning key INTERPHEX 2020 show floor content, exhibitor awards and other onsite programs into virtual offerings. These digital tools offer year-round access to source technologies, products and services and opportunities to learn from leading suppliers to develop and manufacture cost-effective, quality therapeutics for the global population. Keep watching for additional news.”
INTERPHEX Live: Bringing an Onsite Favorite to the Virtual World! Available for viewing beginning in August. INTERPHEX, American Pharmaceutical Review and Pharmaceutical Outsourcing, offer moderated, non-promotional discussions led by Russ Somma, PhD, President, SommaTech Consulting.
- “Biosimilars 2020 and Beyond”Premiering Monday, August 10, 2020 Panelist(s): Rick Morris, Senior Vice President R&D, Pall Biotech; Michiel E. Ultee, PhD, CEO, Ulteemit BioConsulting and Hillel Cohen, PhD, Executive Director for Scientific Affairs, Sandoz Biopharmaceuticals
- “Advancements in Cell and Gene Therapy”Premiering Wednesday, August 12, 2020 Panelist(s): Katy Worrilow, PhD, Founder and CEO, LifeAire Systems, LLC; Amos Thai, PhD, Principal Scientist, Janssen Research & Development; Audrey Greenberg, Co-Founder and Executive Managing Director, The Discovery Labs;, Norman Goldschmidt, President, Genesis AEC and Diane Blumenthal, Head of Technical Operations, Spark Therapeutics, Inc.
- “Updates on What’s New with FDA Inspections”Premiering Monday, August 17, 2020 Panelist(s): Joe McGinnis, Senior Regulatory Compliance Advisor, Johnson & Johnson
- “Pharma Intelligence 2020 State of Investment”Premiering Wednesday, August 19, 2020
